Jorge Insuasty
Corporate Officer/Principal bei PHILIP MORRIS INTERNATIONAL, INC.
Profil
Jorge Insuasty is currently the President-Vectura Fertin Pharma at Philip Morris International, Inc. and the President at Vectura Fertin Pharma, Inc. He previously worked as the Global Head-Development & Neuroscience at Novartis International AG and as the Vice President & Member-Global Leadership Team at Sanofi.
Dr. Insuasty holds a graduate degree from Université de Paris 5 René Descartes.
Aktive Positionen von Jorge Insuasty
| Unternehmen | Position | Beginn |
|---|---|---|
| PHILIP MORRIS INTERNATIONAL, INC. | Corporate Officer/Principal | 15.01.2021 |
| Vectura Fertin Pharma, Inc. | President | 01.01.2023 |
Ehemalige bekannte Positionen von Jorge Insuasty
| Unternehmen | Position | Ende |
|---|---|---|
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
| SANOFI | Chief Tech/Sci/R&D Officer | 23.10.2014 |
Ausbildung von Jorge Insuasty
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SANOFI | Health Technology |
| PHILIP MORRIS INTERNATIONAL, INC. | Consumer Non-Durables |
| Private Unternehmen | 3 |
|---|---|
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
| Université de Paris 5 René Descartes | Consumer Services |
| Vectura Fertin Pharma, Inc. |
